Kimberly Hanson is an experienced professional in the pharmaceutical industry, currently serving as an Executive Therapeutic Specialist in Hepatitis C at Gilead Sciences since September 2015. With a strong focus on client engagement in the specialties of Gastroenterology, Hepatology, and Infectious Disease, Kimberly has contributed to significant volume and market share growth during a competitive launch period. Previous experience includes roles at Shire as a Senior Therapeutic Specialist, launching the Natpara drug for Hypoparathyroidism, and at Genentech in various specialist capacities, where key relationships were built with providers and community outreach conducted. Starting a career at Bristol-Myers Squibb as a Territory Business Manager, Kimberly developed marketing strategies across multiple medical fields. Educational credentials include a BS in Organizational Communications and Management and an MS in Personnel Administration, both from the University of Central Missouri.
This person is not in any teams
This person is not in any offices